Contributors

Yesne Alici, M.D.

Assistant Attending Psychiatrist, Clinical Director of the Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York

Andrew R. Alkis, M.D.

Consultation-Liaison Psychiatrist, Psychiatry Inpatient Services, Novant Health, Forsyth Medical Center, Winston-Salem, North Carolina

David J. Axelrod, M.D., J.D.

Associate Professor, Department of Internal Medicine, Jefferson Medical College; Director, Sickle Cell Program, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Robert Bahnsen, M.D.

Clinical Assistant Professor, Department of Psychiatry and Human Behavior, Thomas Jefferson University, Philadelphia, Pennsylvania

Rosemary Basson, M.D.

Clinical Professor, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada

Madeleine Becker, M.D., M.A.

Director, Consultation Liaison Psychiatry and Hospital Psychiatry, Thomas Jefferson University Hospital, Department of Psychiatry and Human Behavior, Philadelphia, Pennsylvania

Charles H. Bombardier, Ph.D.

Professor, Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington

John Michael Bostwick, M.D.

Professor of Psychiatry, Mayo Clinic College of Medicine, Rochester, Minnesota

William Breitbart, M.D.

Chairman, Jimmie C. Holland Chair in Psychiatric Oncology, Department of Psychiatry and Behavioral Sciences; Attending Psychiatrist, Supportive Care Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center; Professor of Clinical Psychiatry, Department of Psychiatry, Weill Medical College of Cornell University, New York, New York

Rebecca W. Brendel, M.D., J.D.

Director of Law and Ethics, Center for Law, Brain, and Behavior, and Psychiatrist, Massachusetts General Hospital, Boston, Massachusetts; Director, Master of Bioethics Degree Program, and Assistant Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts

E. Sherwood Brown, M.D., Ph.D.

Professor, Aradine S. Ard Chair in Brain Science, and Vice Chairman for Clinical Research, Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas

Brenda Bursch, Ph.D.

Professor, Departments of Psychiatry and Biobehavioral Sciences, and Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California

Alan J. Carson, M.Phil., M.D., FRCPsych, FRCP

Dr Reader in Neuropsychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom

Keira Chism, M.D., M.A.

Associate Director, Consultation Liaison and Hospital Psychiatry, Transplant Psychiatry, Thomas Jefferson University Hospital, Department of Psychiatry and Human Behavior, Philadelphia, Pennsylvania

Harvey Max Chochinov, M.D., Ph.D., FRCPC

Distinguished Professor, Department of Psychiatry; Co-Director, Psycho-Social Oncology Research Group; Director, Manitoba Palliative Care Research Unit, Faculty of Medicine University of Manitoba, Winnipeg, Manitoba, Canada

Michael R. Clark, M.D., M.P.H., M.B.A.

Chair, Department of Psychiatry & Behavioral Health, Inova Health System, Falls Church, Virginia

Catherine C. Crone, M.D.

Associate Professor, Department of Psychiatry, George Washington University School of Medicine, Washington, DC; Clinical Professor of Psychiatry, Virginia Commonwealth University, Richmond, Virginia; Vice Chair, Department of Psychiatry, Inova Fairfax Hospital, Falls Church, Virginia

Ericka L. Crouse, Pharm.D., BCPP, BCGP

Associate Professor, Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia

Daniel Cukor, Ph.D.

Associate Professor, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York

Mary Amanda Dew, Ph.D.

Professor of Psychiatry, Psychology, Epidemiology, Biostatistics, and Clinical and Translational Science; Director, Clinical Epidemiology Program, Western Psychiatric Institute and Clinic; Director, Quality of Life Research, Artificial Heart Program Adult Cardiothoracic Transplantation, University of Pittsburgh School of Medicine and Medical Center, Pittsburgh, Pennsylvania

Andrea F. DiMartini, M.D.

Professor of Psychiatry and Surgery, Western Psychiatric Institute and Clinics, University of Pittsburgh School of Medicine and Medical Center, Starzl Transplant Institute, Pittsburgh, Pennsylvania

Andrew Edelstein, M.D.

Instructor in Clinical Psychiatry, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York

Natacha D. Emerson, Ph.D.

Postdoctoral Fellow, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California

Steven A. Epstein, M.D.

Professor and Chair, Department of Psychiatry, Georgetown University School of Medicine and Physician Executive Director, MedStar Behavioral Health, Washington, D.C.

Jesse R. Fann, M.D., M.P.H.

Professor, Department of Psychiatry and Behavioral Sciences, and Adjunct Professor, Department of Rehabilitation Medicine, University of Washington School of Medicine; Adjunct Professor, Department of Epidemiology, University of Washington School of Public Health; Director, Psychiatry and Psychology Service, Seattle Cancer Care Alliance; Affiliate Investigator, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

Charles V. Ford, M.D.

Professor, Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama

Andrew Francis, Ph.D., M.D.

Professor of Psychiatry, Associate Director of Residency Training, and Director of Neuromodulation Services, Penn State Medical School, Hershey Medical Center, Hershey, Pennsylvania

Oliver Freudenreich, M.D.

Co-Director, Schizophrenia Clinical and Research Program, Massachusetts General Hospital; Associate Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts

Gregory L. Fricchione, M.D.

Director, Benson–Henry Institute for Mind–Body Medicine, Massachusetts General Hospital; Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts

Patricia Gracia-Garcia, M.D., Ph.D.

Psychiatrist, Hospital Universitario Miguel Servet, Zaragoza, Spain

Mark S. Groves, M.D.

Assistant Clinical Professor, Departments of Psychiatry and Neurology, Icahn School of Medicine at Mt. Sinai, New York, New York

Angela S. Guarda, M.D.

Associate Professor, Department of Psychiatry and Behavioral Sciences; Director, Eating Disorders Program, Johns Hopkins Medicine, Baltimore, Maryland

Madhulika A. Gupta, M.D., M.Sc., FRCPC

Professor, Department of Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada

Elspeth Guthrie, M.B., Ch.B., FRCPsych, M.Sc., M.D.

Professor of Psychological Medicine, Institute of Health Sciences, University of Leeds, Leeds, West Yorkshire, United Kingdom

Raed Hawa, M.D.

Associate Professor, Department of Psychiatry, University of Toronto, Centre for Mental Health, University Health Network, Toronto, Ontario

Peter Henningsen, M.D.

Professor and Chair, Department of Psychosomatic Medicine and Psychotherapy, TUM University Hospital, Munich, Germany

J. Greg Hobelmann, M.D., M.P.H.

Chief Medical Officer, Ashley Addiction Treatment, Havre de Grace, Maryland

Michael R. Irwin, M.D.

Distinguished Professor of Psychiatry and Biobehavioral Sciences, UCLA David Geffen School of Medicine; Norman Cousins Chair for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience and Human Behavior; and Director, Cousins Center for Psychoneuroimmunology, Los Angeles, California

Richard Kennedy, M.D.

Assistant Professor, Division of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama

Paul L. Kimmel, M.D.

Clinical Professor of Medicine, Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University, Washington, D.C.

Cynthia K. Kirkwood, Pharm.D., BCPP

Executive Associate Dean for Academic Affairs; Professor, Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia

Christopher Kogut, M.D.

William and Ruth McDonough Professor in Graduate Psychiatric Education and Director of Residency Education, Virginia Commonwealth University School of Medicine, Richmond, Virginia

Lois E. Krahn, M.D.

Professor of Psychiatry, Mayo Clinic College of Medicine; Center for Sleep Medicine, Mayo Clinic, Scottsdale, Arizona

Juliet Kroll, M.A.

Graduate Research Assistant, Clinical Psychology, Department of Psychology, Southern Methodist University, Dallas, Texas

Alexandra Kulikova, M.S.

Clinical Research Coordinator, Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas

Jeanne M. Lackamp, M.D.

Associate Professor, Department of Psychiatry, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

Albert F.G. Leentjens, M.D., Ph.D.

Associate Professor of Psychiatry, Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands

James L. Levenson, M.D.

Professor of Psychiatry, Medicine, and Surgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia

Madeline Li, M.D., Ph.D., FRCPC

Associate Professor, Department of Psychiatry, University of Toronto; Clinician Scientist, Department of Psychosocial Oncology and Palliative Care, Princess Margaret Hospital, Toronto, Ontario, Canada

Ted S. Liao, M.D.

Assistant Professor of Clinical Psychiatry, Georgetown University School of Medicine; Associate Director of Consultation-Liaison Psychiatry Fellowship and Associate Director of Psychiatry Residency Training Program, MedStar Georgetown University Hospital, Washington, D.C.

Antonio Lobo, M.D., Ph.D.

Emeritus Professor. Department of Medicine and Psychiatry, University of Zaragoza, Aragon Health Research Foundation (IIS Aragón), Zaragoza, Spain

Constantine G. Lyketsos, M.D., M.H.S.

Elizabeth Plank Althouse Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, and Chair, Department of Psychiatry, Johns Hopkins Bayview Medical Center, Baltimore, Maryland

Mary Jane Massie, M.D.

Professor of Clinical Psychiatry, Weill Medical College of Cornell University; Attending Psychiatrist, Memorial Sloan-Kettering Cancer Center, New York, New York

Cheryl McCullumsmith, M.D., Ph.D.

Associate Professor, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio

David J. Meagher, M.D., MRCPsych, Ph.D.

Professor of Psychiatry, Graduate Entry Medical School, University of Limerick, Limerick, Ireland

Weronika Micula-Gondek, M.D.

Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins Medicine, Baltimore, Maryland

Kimberley Miller, M.D., FRCPC

Assistant Professor, Department of Psychiatry, University of Toronto; Attending Psychiatrist, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Philip R. Muskin, M.D., M.A.

Professor of Psychiatry and Senior Consultant in Consultation-Liaison Psychiatry at Columbia University Medical Center; Faculty, Columbia University Psychoanalytic Center for Training and Research, New York, New York

Alyson K. Myers, M.D.

Medical Director, Inpatient Diabetes, North Shore University Hospital, Manhasset, New York; Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, East Garden City, New York; and Assistant Professor, Merinoff Center for Patient-Oriented Research at the Feinstein Institute, Northwell Health, Manhasset, New York

Ariana Nesbit, M.D., M.B.E.

Forensic Psychiatry Fellow, Department of Psychiatry, Division of Psychiatry and the Law, University of California, Davis Medical Center, Sacramento, California

Patrick G. O’Malley, M.D., M.P.H., FACP

Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Chiadi U. Onyike, M.D., M.H.S.

Associate Professor, Department of Psychiatry and Behavioral Sciences, Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins School of Medicine, Baltimore, Maryland

James A. Owen, Ph.D. (Deceased)

Associate Professor, Department of Psychiatry and Department of Pharmacology and Toxicology, Queen’s University; Director, Psychopharmacology Lab, Providence Care Mental Health Services, Kingston, Ontario, Canada

Miguel Ángel Quintanilla, M.D., Ph.D.

Attending Psychiatrist, Hospital Clínico Universitario; Instructor in Psychiatry, Department of Medicine and Psychiatry, University of Zaragoza, Zaragoza, Spain

J. J. Rasimas, M.D., Ph.D.

Associate Professor of Psychiatry & Emergency Medicine, University of Minnesota Medical School; Director of Consultation-Liaison Psychiatry, Hennepin County Medical Center, Minneapolis, Minnesota

Keith G. Rasmussen, M.D.

Professor, Mayo Clinic Department of Psychiatry and Psychology, Rochester, Minnesota

Peter M. Rees, M.D., Ph.D.

Neurologist (retired), formerly at Burnaby Hospital, Burnaby, British Columbia, Canada

Thomas Ritz, Ph.D.

Professor of Psychology and Director, Psychobiology of Stress, Emotion, and Chronic Disease Research Program, Department of Psychology, Southern Methodist University, Dallas, Texas

Gary Rodin, M.D., FRCPC

Professor, Department of Psychiatry, University of Toronto; Head, Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Joshua Rosenblat, M.D.

Resident in Psychiatry, Clinician Scientist Program, University of Toronto, Toronto, Ontario, Canada

Deborah Rosenthal-Asher, Ph.D.

Memory and Psychological Services, Inc., Brecksville, Ohio

Pedro Saz, M.D., Ph.D.

Professor of Psychiatry, Department of Medicine and Psychiatry, University of Zaragoza, Zaragoza, Spain

Ronald Schouten, M.D., J.D.

Director, Law and Psychiatry Service, Massachusetts General Hospital, and Associate Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts

Peter A. Shapiro, M.D.

Professor of Psychiatry, Columbia University Medical Center; and Director, Consultation-Liaison Psychiatry Service, New York Presbyterian Hospital–Columbia University Medical Center, New York, New York

Michael C. Sharpe, M.A., M.D., FRCP, FRCPsych

Professor of Psychological Medicine, University of Oxford, Oxford, United Kingdom

Akhil Shenoy, M.D., M.P.H.

Assistant Professor of Psychiatry, Columbia University College of Physicians and Surgeons; Liaison to the  Center for Liver Disease and Transplantation, New York–Presbyterian Hospital Columbia University Medical Center, New York, New York

Felicia A. Smith, M.D.

Chief, Psychiatric Consultation Service; Director, Division of Psychiatry and Medicine, Massachusetts General Hospital; Assistant Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts

Sanjeev Sockalingam, M.D.

Associate Professor, Department of Psychiatry, University of Toronto, Centre for Mental Health, University Health Network, Toronto, Ontario

Wolfgang Söllner, M.D.

President, European Association for Psychosomatic Medicine; Professor of Psychosomatic Medicine and Psychotherapy, Paracelsus Medical University, General Hospital Nuremberg, Germany

Loretta Sonnier, M.D.

Assistant Professor, Department of Psychiatry and Behavior Sciences, Tulane University, New Orleans, Louisiana

Theodore A. Stern, M.D.

Chief Emeritus, Psychiatric Consultation Service, Massachusetts General Hospital; Ned H. Cassem Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts

Donna E. Stewart, C.M., M.D., FRCPC

University Professor and Professor of Psychiatry, Obstetrics and Gynecology, Anesthesia, Family and Community Medicine, and Surgery, University of Toronto Faculty of Medicine; Senior Scientist, Toronto General Hospital Research Institute; Director of Research, University Health Network Centre for Mental Health, Toronto, Ontario, Canada

Jon Stone, Ph.D., FRCP

Dr Reader in Neurology, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom

Margaret L. Stuber, M.D.

Professor and Associate Chair, Medical Student Education, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California

Simone N. Vigod, M.D., M.Sc., FRCPC

Associate Professor, Department of Psychiatry, University of Toronto; Shirley A. Brown Memorial Chair in Women’s Mental Health, Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada

Michael Weaver, M.D., DFASAM

Professor and Medical Director, Center for Neurobehavioral Research on Addiction, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, Houston, Texas

Chelsey Werchan, M.A.

Graduate Research Assistant, Clinical Psychology, Department of Psychology, Southern Methodist University, Dallas, Texas

Elizabeth A. Wise, M.D.

Geriatric Psychiatry Fellow, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

Adam Zeman, M.A., D.M., FRCP

Professor of Cognitive and Behavioural Neurology, Cognitive Neurology Research Group, University of Exeter Medical School, St. Luke’s Campus, Exeter, United Kingdom

Disclosure of Interests

The following contributors to this textbook have indicated a financial interest in or other affiliation with a commercial supporter, manufacturer of a commercial product, and/or provider of a commercial service as listed below:

E. Sherwood Brown, M.D., Ph.D. Research Grant: Otsuka.

Alan J. Carson, M.Phil., M.D., FRCPsych, FRCP Neither I nor my immediate family have any links or financial conflicts of interest with pharmaceutical companies or similar entities. I have given lectures on neuropsychiatric topics at drug company symposia on approximately 10 occasions and received fees of less than $250 dollars on each occasion. I never directly promoted a particular agent. I have received fees for giving independent testimony in court on a variety of neuropsychiatric topics (50% pursuer, 50% defender). I am listed at Companies House London as a director of Dr Jon Stone Ltd, which is a personal services company through which any private medical earnings exclusively for medicolegal work I have are collected and taxed (this is a standard UK arrangement for payment). I am a paid editor of the Journal of Neurology, Neurosurgery, and Psychiatry.

Oliver Freudenreich, M.D. Consultant (Advisory Board): Alkermes, Janssen, and Neurocrine; Research Grants: Avanir, Janssen, Otsuka, and Saladax; Honoraria: Global Medical Education (CME speaker and content developer), Neurocrine (CME talk), and UpToDate (content developer and editor); Royalties: Wolters-Kluwer (content developer), UpToDate (content developer and editor).

Patricia Gracia-Garcia, M.D., Ph.D. I have received honoraria, travel funds, and subscriptions for a scientific meeting from Servier.

Miguel Ángel Quintanilla, M.D., Ph.D. Funding for congress from Lundbeck; grants for survey from Servier.

Jon Stone, Ph.D., FRCP Neither I nor my immediate family have any links or financial conflicts of interest with pharmaceutical companies or similar entities. I have received fees for giving independent testimony in Court on a variety of neuropsychiatric topics (60% pursuer, 40% defender). I am listed at Companies House London as a director of Dr Jon Stone Ltd, which is a personal services company through which any private medical earnings exclusively for medicolegal work I have are collected and taxed (this is a standard UK arrangement for payment). I receive royalties from UpToDate for articles relating to conversion disorder. I run a self-help website (www.neurosymptoms.org) that is free to users and carries no advertising or sponsorship.

Simone N. Vigod, M.D., M.Sc., FRCPC Research Support: Canadian Institutes for Health Research, Ontario Ministry of Health and Long-Term Care, University of Toronto, and Women’s College Hospital in Toronto; Royalties: UpToDate (writing of several chapters on maternal mental health).

Adam Zeman, M.A., D.M., FRCP I received an unrestricted grant of £15,132.53 from UCB in 2018 to fund development of our sleep disorders service though creation of a “Clinical Physiologist Sleep Specialist” role. I undertake occasional medicolegal work, and am sole Director of a company providing this service, Azimuth Medical Consultants Ltd.

The following contributors stated that they had no competing interests during the year preceding manuscript submission:

Andrew R. Alkis, M.D.; David J. Axelrod, M.D., J.D.; Robert Bahnsen, M.D.; Rosemary Basson, M.D.; Madeleine Becker, M.D., M.A.; Charles H. Bombardier, Ph.D.; William Breitbart, M.D.; Rebecca W. Brendel, M.D., J.D.; Brenda Bursch, Ph.D.; Keira Chism, M.D., M.A.; Catherine C. Crone, M.D.; Daniel Cukor, Ph.D.; Mary Amanda Dew, Ph.D.; Andrea F. DiMartini, M.D.; Natacha D. Emerson, Ph.D.; Jesse R. Fann, M.D., M.P.H.; Charles V. Ford, M.D.; Andrew Francis, Ph.D., M.D.; Gregory L. Fricchione, M.D.; Angela S. Guarda, M.D.; Madhulika A. Gupta, M.D., M.Sc., FRCPC; Peter Henningsen, M.D.; Lois E. Krahn, M.D.; Jeanne M. Lackamp, M.D.; Albert F. G. Leentjens, M.D., Ph.D.; James L. Levenson, M.D.; Antonio Lobo, M.D., Ph.D.; Weronika Micula-Gondek, M.D.; Alyson K. Myers, M.D.; Patrick G. O’Malley, M.D., M.P.H., FACP; J. J. Rasimas, M.D., Ph.D.; Keith G. Rasmussen, M.D.; Deborah Rosenthal-Asher, Ph.D.; Pedro Saz, M.D., Ph.D.; Peter A. Shapiro, M.D.; Michael C. Sharpe, M.A., M.D., FRCP, FRCPsych; Akhil Shenoy, M.D., M.P.H.; Sanjeev Sockalingam, M.D.; Loretta Sonnier, M.D.; Margaret L. Stuber, M.D.; Michael Weaver, M.D., DFASAM.